Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription 01.06.2026 11 AIDS 1 Antimicrob Agents Chemother 1 BMC Pediatr 6 Clin Infect Dis 4 J Acquir Immune Defic Syndr 2 J Infect Dis 1 J Med Virol 1 J Virol 1 Lancet Infect Dis 1 Nat Rev Neurol 1 PLoS Med 10 PLoS One 2 PLoS Pathog 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. LIANG W, Zhang L, Wang B, Ben H, et al
   Exposure to size-specific particulate matter accelerates DNA methylation aging in people living with HIV.
   AIDS. 2026 May 26. doi: 10.1097/QAD.0000000000004554.
   PubMed         Abstract available
   
   
2. MAHIDA K, Jagtap SR
   Letter to the editor regarding "Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy".
   AIDS. 2026;40:1050-1051.
   PubMed        
   
   
3. CALCAGNO A, Strano M, Lolatto R, Vercesi R, et al
   Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registry.
   AIDS. 2026;40:1045-1049.
   PubMed         Abstract available
   
   
4. AHUJA S, Maurer T, Sales C, Chemtai L, et al
   Implementation of teledermatology to identify and expedite care for Kaposi sarcoma.
   AIDS. 2026;40:1043-1045.
   PubMed         Abstract available
   
   
5. RYSCAVAGE P, Knable C, Taylor G
   Low measles seroprotection among adults with perinatally acquired HIV.
   AIDS. 2026;40:1041-1043.
   PubMed         Abstract available
   
   
6. OROZCO F, Benham C, Xiang C, Vemulapalli A, et al
   Leveraging HIV/AIDS infrastructure for sustainable healthcare services in sub-Saharan Africa.
   AIDS. 2026;40:1034-1038.
   PubMed        
   
   
7. JARVIS JN, Sivile S
   Advanced HIV disease.
   AIDS. 2026;40:1031-1033.
   PubMed        
   
   
8. ALIYU AT, Dakum PS, Ryscavage P, Blanco N, et al
   High blood pressure and associated metabolic disorders among young adults with and without perinatal HIV.
   AIDS. 2026 May 26. doi: 10.1097/QAD.0000000000004548.
   PubMed         Abstract available
   
   
9. HARRIS DA, Germano Toledo R, Hacker M, Wamakima B, et al
   Persistent or recurrent cervical dysplasia in women living with HIV after treatment for high-grade dysplasia in Botswana.
   AIDS. 2026 May 26. doi: 10.1097/QAD.0000000000004551.
   PubMed         Abstract available
   
   
10. MCFARLANE WJ, Flemming JA, Martinez-Cajas JL, Peng Y, et al
    Liver disease risk attributable to HCV, HIV, and HCV-HIV coinfection: an interaction analysis.
    AIDS. 2026 May 26. doi: 10.1097/QAD.0000000000004555.
    PubMed         Abstract available
    
    
11. NICHOLLS EJ, Bicarregui P, Brewster A, Ghosh I, et al
    A systematic review of qualitative research on HIV and food insecurity in high-income countries.
    AIDS. 2026 May 26. doi: 10.1097/QAD.0000000000004552.
    PubMed         Abstract available
    
    

    
    Antimicrob Agents Chemother

12. MISHRA T, Edwards A, Wu L
    Pharmacological METTL3 inhibition attenuates HIV-1 latency reversal in CD4(+) T cells.
    Antimicrob Agents Chemother. 2026 May 29:e0040026. doi: 10.1128/aac.00400.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

13. ROSE PC, Rabie H, de Lacy R, Riordan G, et al
    Neonatal HIV prophylaxis is associated with accelerated presentation and clinical progression of MPV17-related mitochondrial neurohepatopathy.
    BMC Pediatr. 2026 May 26. doi: 10.1186/s12887-026-06984.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

14. COGHILL AE, Bender Ignacio R
    Further unraveling the association between HIV, immune suppression, and cancer survival.
    Clin Infect Dis. 2026 May 29:ciag334. doi: 10.1093.
    PubMed        
    
    
15. HAAS CB, Shiels MS, Luo Q, Pfeiffer RM, et al
    Markers of immune function and survival among cancer patients with HIV in the United States: a population-based registry linkage study.
    Clin Infect Dis. 2026 May 29:ciag333. doi: 10.1093.
    PubMed         Abstract available
    
    
16. FESER M, Maphosa T, Shroufi A, Rangaraj A, et al
    Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi.
    Clin Infect Dis. 2026 May 28:ciag270. doi: 10.1093.
    PubMed         Abstract available
    
    
17. BEHUHUMA N, Gasa G, Derache A, Nhlapo B, et al
    Efficacy and acceptability of liraglutide for obesity in people with HIV: results of an open-label clinical trial in South Africa.
    Clin Infect Dis. 2026 May 28:ciag337. doi: 10.1093.
    PubMed         Abstract available
    
    
18. LEE TH, Bhattacharya D, Kim HN
    Don't Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of HIV.
    Clin Infect Dis. 2026 May 27:ciag322. doi: 10.1093.
    PubMed         Abstract available
    
    
19. WELD ED, Scott RK
    Long-Acting Antiretroviral Therapy to Treat Advanced Human Immunodeficiency Virus in Pregnancy: Let Not Delayed Detection Be the Enemy of the Good.
    Clin Infect Dis. 2026 May 25:ciag291. doi: 10.1093.
    PubMed        
    
    

    
    J Acquir Immune Defic Syndr

20. WANG H, Jonas KJ, van de Vijver D
    Epidemiological impact of prioritising long-acting injectable cabotegravir to MSM with low PrEP use adherence in the Netherlands: A mathematical modelling study.
    J Acquir Immune Defic Syndr. 2026 May 25. doi: 10.1097/QAI.0000000000003882.
    PubMed         Abstract available
    
    
21. CASTELLANO C, Moran CA, Nguyen MT, Ramesh V, et al
    Incidence and Risk Factors for Non-AIDS Comorbidities Following COVID-19 in People Living with HIV in Atlanta, Georgia.
    J Acquir Immune Defic Syndr. 2026 May 26. doi: 10.1097/QAI.0000000000003901.
    PubMed         Abstract available
    
    
22. WILLKENS M, Issarow B, Kisigo GA, Kabakama S, et al
    Sustainability of the Effects of Linkage Case Management on Posthospitalization HIV Outcomes: The Daraja Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2026 May 26. doi: 10.1097/QAI.0000000000003900.
    PubMed         Abstract available
    
    
23. SALTINI P, Cozzi-Lepri A, Bozzi G, Tavelli A, et al
    Pre-ART platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio and the risk of non-AIDS-events, AIDS-events and mortality in people with HIV.
    J Acquir Immune Defic Syndr. 2026 May 26. doi: 10.1097/QAI.0000000000003903.
    PubMed         Abstract available
    
    

    
    J Infect Dis

24. DIAMOND TL, Grandhi A, Fuszard M, Xu Y, et al
    Switching to Daily Doravirine/Islatravir (100/0.25 mg) Maintains Viral Suppression Through Week 48 Despite Baseline Non-Nucleoside Reverse Transcriptase Inhibitor Resistance-Associated Mutations or M184I/V in Proviral DNA.
    J Infect Dis. 2026 May 29:jiag257. doi: 10.1093.
    PubMed         Abstract available
    
    
25. XUE K, Shi Y, Gan Y, Zhang R, et al
    Altered Diffusion Tensor Image Analysis Along the Perivascular Space in People Living with HIV: Association with Cognition and Diagnostic Utility for Asymptomatic Neurocognitive Impairment.
    J Infect Dis. 2026 May 23:jiag265. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

26. ZHENG ZM, Majerciak V
    ORF57/MTA in KSHV Biology and Pathogenesis: Update From 2015.
    J Med Virol. 2026;98:e70979.
    PubMed         Abstract available
    
    

    
    J Virol

27. FIGUEROA ACOSTA DM, Valencia TR, Li H, Chen BK, et al
    Endocytic motif on HIV-1 Env regulates cleavage status and antibody neutralization of cell-free and cell-to-cell infection.
    J Virol. 2026 May 28:e0154225. doi: 10.1128/jvi.01542.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

28. DAWSON R, Diacon AH, Variava E, Moloantoa T, et al
    Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trial.
    Lancet Infect Dis. 2026 May 29:S1473-3099(26)00143.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

29. HECKMANN JM, Floudiotis N, Makanjuola A, Ogunniyi A, et al
    Motor neuron disease in Africa: a critical appraisal of the literature.
    Nat Rev Neurol. 2026 May 26. doi: 10.1038/s41582-026-01221.
    PubMed         Abstract available
    
    

    
    PLoS Med

30. SWARTWOOD NA, Singh N, Mortazavi SA, Can MH, et al
    Differences in tuberculosis prevalence by sex in low- and middle-income countries over 1993-2025: A systematic review and meta-analysis.
    PLoS Med. 2026;23:e1005114.
    PubMed         Abstract available
    
    

    
    PLoS One

31. OLATOREGUN OJ, Hightow-Weidman L, Mulawa M, Jennings L, et al
    Adapting a medication adherence app for adolescents and young adults in Makurdi, Benue State: The Lu Dedoo Project.
    PLoS One. 2026;21:e0350279.
    PubMed         Abstract available
    
    
32. ROSSI SL, Cheng DM, Sereda Y, Truong V, et al
    COVID-19 pandemic-related stress and substance use behaviors among people with HIV - a mixed method analysis.
    PLoS One. 2026;21:e0349567.
    PubMed         Abstract available
    
    
33. SPROUL D, McCaul M, Hanekom G
    Contraceptive uptake and characteristics in the immediate postpartum period among women attending Tygerberg Academic Hospital.
    PLoS One. 2026;21:e0349790.
    PubMed         Abstract available
    
    
34. YAN H
    HIV/AIDS burden, attributable risk factors, and projections among reproductive-age adults in China, 1990-2035: A GBD 2023 analysis.
    PLoS One. 2026;21:e0350196.
    PubMed         Abstract available
    
    
35. KOSGEI J, Jaoko W, Oyugi J, Burns N, et al
    Epidemiology of hepatitis B virus co-infection among people living with HIV in four countries in sub-Saharan Africa.
    PLoS One. 2026;21:e0337789.
    PubMed         Abstract available
    
    
36. SMITH DG, Castro C, Pichilingue-Reto P, Dean CG, et al
    Knowledge gaps and structural barriers to prescribing pre-exposure prophylaxis among healthcare providers in North Louisiana: A cross-sectional study.
    PLoS One. 2026;21:e0346890.
    PubMed         Abstract available
    
    
37. MOLDOKMATOVA A, Pan-Ngum W, Ariana P, Franco C, et al
    Potential reasons for the decline of new HIV cases among people who inject drugs (PWID) in Kyrgyzstan.
    PLoS One. 2026;21:e0348970.
    PubMed         Abstract available
    
    
38. SCHAUB R, MacDonald-Ottevanger MS, Hoang S, Pisoni A, et al
    A cross-border seroprevalence study on HBV, HCV, HDV and HIV in remote Amazonian communities on the border between French Guiana and Suriname.
    PLoS One. 2026;21:e0344187.
    PubMed         Abstract available
    
    
39. CHUNG WW, Lai PSM, Sri Ponnampalavanar SS, Chiew TK, et al
    Views, barriers, and facilitators of people living with human immunodeficiency virus and healthcare professionals regarding the use of a mobile health application to improve HIV self-care in Malaysia.
    PLoS One. 2026;21:e0349144.
    PubMed         Abstract available
    
    
40. OWUOTH J, Nwoga C, Sing'oei V, Yates A, et al
    HIV incidence among sexually active young males and females in Kisumu County, Western Kenya.
    PLoS One. 2026;21:e0349111.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

41. LODDO A, Delobel P, Vellas C
    Positioning HIV SMRTcap within the HIV reservoir toolbox.
    PLoS Pathog. 2026;22:e1014257.
    PubMed        
    
    
42. 
    Editorial Note: Recruitment of a SAP18-HDAC1 Complex into HIV-1 Virions and Its Requirement for Viral Replication.
    PLoS Pathog. 2026;22:e1014251.
    PubMed        
    
    

    
    Vaccine

43. JANECZKO M, Kubinski K, Wawiorka L
    Antifungal vaccine development: where we are, where we are headed.
    Vaccine. 2026;86:128766.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum